- Home
- HOLOW vs MDCXW Comparison
HOLOW vs MDCXW Comparison
Compare HOLOW & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOLOW | MDCXW |
|---|---|---|
| Founded | N/A | N/A |
| Country | China | Canada |
| Employees | 64 | 12 |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HOLOW | MDCXW |
|---|---|---|
| Price | $0.09 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.9K | 1.8K |
| Earning Date | 03-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,242,196.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 326.95 | N/A |
| 52 Week Low | $0.07 | $0.45 |
| 52 Week High | $0.23 | $3.50 |
Technical Indicators
Market Signals| Indicator | HOLOW | MDCXW |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 53.94 |
| Support Level | $0.08 | $0.63 |
| Resistance Level | $0.11 | $1.14 |
| Average True Range (ATR) | 0.01 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 77.98 |
Price Performance
Historical ComparisonAbout HOLOW MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About MDCXW Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.